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Background: Few studies have been performed in children with suspected betalactam
allergy. We aimed to assess the role of the drug provocation test (DPT) with betalactams in
a paediatric setting and to study the association between allergy to betalactam antibiotics
and other allergic diseases.
Methods: We included all the patients under 15 years old who were consecutively referred
to the Immunoallergy Department, Dona Estefaˆnia Hospital, Portugal (January 2002 to
April 2008) for a compatible history of allergic reaction to betalactam. All were submitted
to a DPT. Children were proposed to perform skin tests (ST) to betalactam antibiotics
followed by DPT. If they decline ST, a DPT with the culprit drug was performed.
Results: We studied 161 children, 60% were boys, with a median age of 5 years old at the
time of the DPT. Thirty-three patients (20.5%) had an immediate reaction and 33 (20.5%) a
non-immediate reaction. The severity of the reported reactions was low in most cases.
Skin tests to betalactams were performed in 47 children and were positive in 8. DPT was
positive in only one (3.4%) of the patients skin tested and in 11 (13.4%) of those not skin
tested. The severity of the DPT reaction was low. Asthma and food allergy were associated
with a positive DPT in the later group.
Conclusions: DPT seems a safe procedure even in the absence of ST in non-severe cases.
This could be a practical option in infants and pre-school children, where ST are painful
and difﬁcult to perform. Additional caution should be taken in children with asthma and
food allergy.
& 2009 SEICAP. Published by Elsevier Espan˜a, S.L. All rights reserved.SEICAP. Published by Elsevier Espan˜a, S.L. All rights reserved.
ail.com (M. Chambel).
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Allergy to betalactam antibiotics is the most common cause
of adverse drug reactions mediated by speciﬁc immunolo-
gical mechanisms. Less than 10% of patients treated with
betalactam antibiotics report an adverse drug reaction
suggestive of having an immunological mechanism.1,2 In
children, the prevalence of allergic adverse reactions to
betalactam seems to be signiﬁcantly lower than in adults, as
in paediatric age infectious diseases are responsible for the
clinical picture.3,4
In clinical practice, patients who have experienced a drug
reaction are frequently categorised as being allergic to the
culprit drug without any further investigation. This leads to
frequent over-diagnosis of drug allergy. In fact, only 10–20%
of patients reporting a history of penicillin allergy are truly
allergic when correctly assessed.5 Over-diagnosis of peni-
cillin allergy in the paediatric population is a cause of
concern, with the accompanying increases in health costs.6
According to the European Network for Drug Allergy
(ENDA), the diagnosis of betalactam antibiotics allergy
should be based on the clinical history, skin testing (prick
and intradermal tests), in vitro laboratory tests (namely
determination of speciﬁc IgE to the betalactam) and drug
provocation tests.7,8 Skin prick tests are the safest and
easiest tests for immediate drug reactions but are only
moderately sensitive. Intradermal tests are more sensitive
but carry a higher risk to serious adverse reactions. These
could be difﬁcult to perform on children under 6 years old
because of patient fear, as the tests are more invasive and
painful.9
Few studies have been performed in children with
suspected betalactam allergy. In these studies, allergy to
this class of antibiotics was diagnosed by skin tests in
4.9–40% of children.10
In this study we aimed to assess the role of the drug
provocation test with betalactam in a paediatric setting. We
also sought to study the association between allergy to
betalactam antibiotics and other allergic diseases, as this is
not clear in the literature.Methods
We included all consecutive patients under 15 years of age
who, over a six-year period (January 2002 to April 2008),
were referred to the Immunoallergy Department of the Dona
Estefaˆnia Hospital, Portugal, due to a compatible past
clinical history of allergic reaction to betalactamic anti-
biotics. All of them were submitted to a drug provocation
test (DPT). It was proposed that children be ﬁrst skin tested
to betalactam antibiotics (Penicilloyl-Polylysine – PPL, Minor
Determinant Mixture – MDM, penicillin, amoxicillin, amox-
icillin with clavulanic acid and cefuroxime) followed by a
DPT in the following weeks. Those children with a mild
reaction, non-collaborant (intensive crying, motor agitation
because of fear), were proposed to perform a DPT with the
culprit drug or with an alternative drug without previous
skin testing. Speciﬁc IgE to amoxicillin, penicillin G and V
was performed independently of the chronology of the
reaction (Immulites 2000, Siemens Healthcare Diagnostics,
Deerﬁeld, USA).Data collection
Clinical data were registered before the investigation and
included questions derived from the ENDA drug allergy
questionnaire.11 Demographic parameters, clinical presen-
tation, score of the reaction, chronology of the reaction,
allergy clinical history, airborne allergen skin prick test
results, time delay from the adverse drug reaction to ﬁnal
diagnosis, implicated antibiotic, drug provocation test
antibiotic, betalactam skin tests and drug provocation test
results were all analysed. Asthma was considered according
to consensus deﬁnitions.12 IgE-mediated food allergy was
established on the basis of standardised criteria.13 Reactions
were classiﬁed as immediate reactions, which occurred
within one hour after antibiotic administration, or non-
immediate reactions, which became apparent one hour
after the antibiotic exposure.14 The Ring and Messmer
classiﬁcation was used for immediate reactions.15 Non-
immediate reactions were graded as mild (no treatment
required), moderate (patient responded readily to appro-
priate treatment and no hospitalisation was needed), or
severe (reaction required treatment in hospital, was life-
threatening or resulted in death). Anaphylaxis was deﬁned
as a severe, life-threatening generalised or systemic
hypersensitivity reaction.16
Skin tests
Skin tests were performed according to ENDA recommenda-
tions,9 ﬁrst as prick tests and, if negative, were followed by
intradermal tests (IDT). Prick and intradermal tests were
performed into the non-irritative concentrations.7 A prick
test was considered positive if after 15 min the size of the
wheal was at least 3 mm in diameter. For IDT, positivity was
considered when the size of the initial wheal increased by at
least 3 mm in diameter after 20 min. Late reading was
performed in those who mentioned a positive result in the
following 72 h.
Drug provocation tests
Drug provocation tests were performed according to
recommendations.17 Patients’ parents signed informed
consent before the DPT. The DPTentails ingesting increasing
doses of the antibiotic, every 30 min, until the appropriate
cumulative dose per weight was reached. At home, daily
therapeutic doses were prescribed for 5 days. Parents were
advised to stop treatment, to contact their doctor, and to
take oral antihistamines and/or corticosteroids if they
experienced a reaction. Administration was performed on
an open challenge protocol by a physician, with full
resuscitation back-up. Patients not skin tested or with
negative skin tests to betalactams were proposed to be
tested with the culprit antibiotic. Those patients with
positive skin tests to betalactams or in whom their parents
refused to be tested with the culprit drug were submitted to
an alternative betalactam antibiotic.
The DPT result was considered positive if any symptom or
sign of a drug reaction was clearly documented by a
physician (urticaria, maculopapular eruption, bronchos-
pasm, rhinoconjunctivitis, laryngeal oedema, or anaphylaxis)
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end of the antibiotic intake.
Statistical analysis
An exploratory analysis of the variables of interest was
carried out. Frequencies, percentages, and means were
calculated using classical statistics.18 The Fisher exact test
was used to compare proportions. The Mann-Whitney was
used to compare means in different groups.
The level of signiﬁcance considered was a¼0.05 although
p-values greater than 0.05 and lower than 0.1 were
considered in order to indicate trends.18 SPSS (Statistical
Package for the Social Sciences, 15.0; Chicago, Illinois, USA)
for Windows was used to analyse the data.
Results
The study ﬂow chart is presented in Figure 1. Between
January 2002 and April 2008, 161 children were referred to
our department for a compatible past clinical history of
betalactam allergy. The majority were boys (60%), with a
median age of 3 years at the time of the reaction (Table 1).
With respect to the chronology of the adverse reaction,
33 patients (20.5%) had immediate reactions, and 33 non-
immediate reactions (20.5%). Ninety-ﬁve (59%) patients
could not remember the time elapsed between antibiotic
intake and their subsequent reaction(s). Aminopenicillins
and benzylpenicillin counted for more than 75% of the
implicated antibiotics. Out of the total of 161 patients, 47
(29%) were skin tested to betalactams.
Isolated skin eruptions (maculopapular exanthema, urti-
caria, angio-oedema, undeﬁned rash) were the most
frequent clinical presentations, in 140 patients (87%). For
the most part these were immediate reactions and accord-
ing to the Ring and Messmer classiﬁcation these were
Grade I. There was one anaphylaxis. The non-immediate
reactions were mild and moderate in all cases.
Allergic diseases, namely asthma, occurred in 25.5% of
the children, which is higher than the Portuguese paediatric
asthma prevalence. Skin tested children to betalactams
were older and had a higher frequency of asthma compared
to those who were not skin tested (42.6% versus 18.4%). The
same was true for allergic rhinitis (46.8% versus 23.7%);
atopic eczema (14.9% versus 5.3%); and positive airborne161 pati
47 patients skin tested










Figure 1 Study ﬂow chart. DPT: drug provocallergen skin tests (51% and 16.7%). Patients not skin tested
to betalactams had more IgE mediated food allergy. The
implicated food allergens were milk, egg and ﬁsh.
Of the 47 children skin tested to betalactams, eight (17%)
had a positive reaction, all with intradermal tests (Table 2):
four to PPL, two to MDM, and another two for amoxicillin
with clavulanic acid. No delayed skin reactions documented.
Speciﬁc IgE to penicillin was performed in 106 (66%) of the
patients and was positive in only two (1.9%), both with
positive skin tests to betalactams. Speciﬁc IgE to penicillin
was positive in a signiﬁcantly higher number of children with
a positive skin test (7.7% against 0%). From those with a
negative IgE, 12.5% had a positive skin test.
The majority of patients included in this study were
submitted to a DPT with the culprit drug. 3.4% of the
patients skin tested to betalactams had a positive challenge
against 13.4% in those not skin tested. Skin tests were
negative in those patients with a positive DPT. About 40% of
the patients were tested with an alternative drug. This was
the choice even in nine patients with negative skin tests to
betalactams, as their parents feared a serious reaction. Most
of the patients who underwent the alternative DPT were
challenged with cephalosporin and were negative (98.4% of
patients had a negative DPTwith an alternative drug). At the
time of the DPT with the culprit drug, skin tested children
were older (median age of 7 years versus 4 years), which
may represent a longer delay until the diagnosis.
The median time that elapsed between the reaction and
the allergy work up (time delay) was signiﬁcantly higher for
children skin tested to betalactams (not skin tested: median
of one year; skin tested: median of two years).
Among the 12 patients with a positive DPTwith the culprit
drug, four had an immediate adverse drug reaction (ADR), in
one a non-immediate ADR, and in seven it was unknown. The
severity of those ADR was mild. The DPTreaction occurred in
all cases one hour after the intake. Skin eruption was the
manifestation in all cases. In all the positive DPT with the
culprit drug, speciﬁc IgE to penicillin was negative.
When we analyse only the group of children not skin
tested to betalactams and submitted them to a DPTwith the
culprit antibiotic (Table 3), we found no ﬁnd signiﬁcant
gender and age differences between positive and negative
DPT groups. Concerning the chronology of ADR, immediate
reactions represented 36% of the positive DPTand 17% of the
negative DPT. There was a trend towards higher prevalence
of asthma in those with a positive DPT (36.4% in the positiveents










ation test; ST: skin tests to betalactams.
Table 1 Clinical characteristics of all the patients
Total Not skin tested Skin tested p-value
Total number 161 114 (70.8%) 47 (29.2%)
Gender 0.425
Male 96 (59.6%) 69 (60.5%) 27 (57.4%)
Female 65 (40.4%) 45 (39.5%) 20 (42.6%)
Age at the time of the ADR – years (Q1–Q3) 3 (1–6) 2 (1–4) 4.5 (2–6.5) 0.001
r3 years old 85 (74.8%) 65 (57%) 20 (42.6%)
Z4 years old 62 (38.5%) 36 (31.6%) 26 (55.3%)
Unknown 14 (8.7%) 13 (11.4%) 1 (2.1%)
Implicated antibiotic – n (%) 0.012
Unknown 5 (3.1%) 1 (0.9%) 4 (8.5%)
Amoxicillin 40 (24.8%) 32 (28.1%) 8 (17.1%)
Amoxicillinþclavulanic acid 73 (45.3%) 50 (43.9%) 23 (48.9%)
Benzylpenicillin 10 (6.2%) 4 (3.5%) 6 (12.8%)
Flucloxacillin 4 (2.5%) 3 (2.6%) 1 (2.1%)
Cephalosporin 29 (18%) 24 (21%) 5 (10.6%)
Chronology of the ADR 0.906
Immediate 33 (20.5%) 25 (21.9%) 8 (17%)
Non-immediate 33 (20.5%) 22 (19.3%) 11 (23.4%)
Unknown 95 (59%) 67 (58.8%) 28 (59.6%)
Classiﬁcation of the reaction
Immediate 1.000
Grade I 28 (17.4%) 22 (19.3%) 6 (12.7%)
Grade II 0 (0%) 0 (0%) 0 (0%)
Grade III 5 (3.1%) 3 (2.6%) 2 (4.2%)
Grade IV 0 (0%) 0 (0%) 0 (0%)
Non-immediate 0.608
Mild 15 (9.3%) 10 (8.8%) 5 (10.6%)
Moderate 18 (11.2%) 12 (10.5%) 6 (12.8%)
Severe 0 (0%) 0 (0%) 0 (0%)
Clinical presentation of the ADR 0.272
Unknown 5 (3%) 2 (1.8%) 3 (6.4%)
Skin eruption 140 (87%) 103 (90.3%) 37 (78.7%)
Gastrointestinal 12 (7.5%) 8 (7%) 4 (8.5%)
Respiratory 3 (1.9%) 1 (0.9%) 2 (4.3%)
Anaphylaxis 1 (0.6%) 0 (0%) 1 (2.1%)
Airborne allergen skin tests 0.000
Positive 43 (26.7%) 19 (16.7%) 24 (51%)
Negative 54 (33.5%) 44 (38.6%) 10 (21.2%)
Not performed 64 (39.8%) 51 (44.7%) 13 (27.6%)
Asthma diagnosis 0.002
Yes 41 (25.5%) 21 (18.4%) 20 (42.6%)
No 120 (74.5%) 93 (81.6%) 27 (57.4%)
Allergic rhinitis diagnosis 0.005
Yes 49 (30.4%) 27 (23.7%) 22 (46.8%)
No 112 (69.6%) 87 (76.3%) 25 (53.2%)
Atopic eczema diagnosis 0.056
Yes 13 (8%) 6 (5.3%) 7 (14.9%)
No 148 (92%) 108 (94.7%) 40 (85.1%)
Food allergy diagnosis 0.234
Yes 15 (9.3%) 13 (11.4%) 2 (4.3%)
No 146 (90.7%) 101 (88.6%) 45 (95.7%)
Q1: 1st quartile; Q3: 3rd quartile; ADR: adverse drug reaction.
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diagnosis of food allergy was associated with a positive DPT
(27.3% in the positive group versus 5.6% in the negative
group, p¼0.047).Discussion
Adverse drug reactions are an important public health issue.
They are considered somewhere between the fourth and
Table 2 Results of the investigation performed to all the patients
Total Not skin tested Skin tested p-value
Skin test results (betalactams)
Positive 8 (17%) – 8 (17%)
Negative 39 (83%) – 39 (83%)
IgE penicillina result 0.058
Positive 2 (1.9%) 0 (0%) 2 (7.7%)
Negative 104 (98.1%) 80 (100%) 24 (92.3%)
Result of the DPT – Culprit betalactam 0.179
Positive 12 (8.9%) 11 (13.4%) 1 (3.4%)
Negative 100 (91.1%) 71 (86.6%) 29 (96.6%)
Result of the DPT – Alternative antibiotic 0.303
Positive 1 (1.6%) 0 (0%) 1 (6.3%)
Negative 62 (98.4%) 46 (100%) 16 (95%)
Time delay in the diagnosis – years (Q1–Q3) 1 (0–2) 1(0–2) 2(1–4) 0.006
oOne year 42 (26.1%) 37 (32.6%) 6 (12.8%)
4One year 105 (65.2%) 65 (57.0%) 40 (85.1%)
Unknown 14 (8.9%) 13 (11.4%) 1 (2.1%)
Age at the time of the DPT – years (Q1–Q3)b 5 (3–7) 4 (2–6) 7 (5–9) 0.000
aAmoxicillin, Penicillin G and V.
bAge at the time of the DPTwith the culprit drug; Q1: 1st quartile; Q3: 3rd quartile; DPT: Drug provocation test.
Table 3 Clinical characteristics of the patients not skin tested to betalactam and submitted to a DPT with the culprit
antibiotic
Total DPT positive DPT negative p-value
Total number 82 11 71
Gender 0.516
Male 47 (57.3%) 5 (45.5%) 42 (59.2%)
Female 35 (42.7%) 6 (54.5%) 29 (40.8%)
Age at the time of the DPT – years (Q1–Q3) 4 (2-6) 3 (2-4) 4 (3-6) 0.327
Age at the time of the ADR 0.709
r3 years old 49 (59.8%) 7 (63.6%) 42 (59.2%)
Z4 years old 23 (28.0%) 2 (18.2%) 21 (29.6%)
Unknown 10 (12.2%) 2 (18.2%) 8 (11.2%)
Chronology of the ADR 0.279
Immediate 16 (19.5%) 4 (36.4%) 12 (16.9%)
Non-immediate 15 (18.3%) 1 (9.0%) 14 (19.7%)
Unknown 51 (62.2%) 6 (54.5%) 45 (63.4%)
Asthma diagnosis 0.087
No 68 (82.9%) 7 (63.6%) 61 (85.9%)
Yes 14 (17.1%) 4 (36.4%) 10 (14.1%)
Allergic rhinitis diagnosis 1.000
No 61 (74.4%) 8 (72.7%) 53 (74.6%)
Yes 21 (25.6%) 3 (27.3%) 18 (25.4%)
Atopic eczema diagnosis 1.000
No 77 (93.9%) 11 (100%) 66 (93.0%)
Yes 5 (6.1%) 0 (0%) 5 (7%)
Food allergy diagnosis 0.047
No 75 (91.5%) 8 (72.7%) 67 (94.4%)
Yes 7 (8.5%) 3 (27.3%) 4 (5.6%)
DPT: drug provocation test; ADR: adverse drug reaction; Q1: 1st quartile; Q3: 3rd quartile.
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are used in a proper manner, in appropriate doses and for
approved indications.19 According to a meta-analysis,20 theoverall incidence of ADR in hospitalised children was 9.53%
and severe reactions accounted for 12.29%. The overall rate
of paediatric hospital admissions due to ADRs was 2.09%;
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patient children the overall incidence of ADR was 1.46%.
It is well known that most patients with a suspected drug
allergy have negative responses in skin and challenge tests.
This is true for adults21 and for children. In a Portuguese
study, only 7% of the children with a self-reported drug
allergy had a conﬁrmed diagnosis.22 In children, true non-
immediate allergic drug reactions associated with skin
eruptions seem lower than in adults and are commonly
attributed to infections.4 The diagnostic work up for drug
allergy is complex and time consuming. A diagnostic
protocol which includes skin testing to betalactams is
considered useful in clarifying the nature of the reaction.14
In the present study we have studied 161 consecutive
children seen at our outpatient clinic referred for a
suspected betalactam antibiotic allergy. A drug allergy
diagnosis was established in only 13% of the patients non-
skin tested and in 19% of the skin tested to betalactams
(nine children: eight by skin tests and in one trough DPT).
This fact supports the idea that most of the suspected
reactions to this class of antibiotics are not a true allergic
phenomenon and are probably related with the infectious
process.3,4 Our results are slightly lower than the results of
Pichichero23 and differ from those found by other
authors.10,24 We should note that the frequency of positive
tests to betalactams found in the present study is similar to
the results reached in adult studies.21,25
Despite the lower incidence of all positive DPT in the
group skin tested, they have a higher time delay to the
diagnosis than the non-skin tested group. That could be due
to the fact that skin tests to betalactams are not readily
available and a ‘‘waiting strategy’’ was taken in skin-tested
children in order to achieve an older age. The younger age
at the time of the ADR is according to the fact that most of
the DPTs were negative and an older age is associated with
a higher antibiotic exposition. It was, however, surprising
that 64% of the positive DPT were in children younger than
3 years.
Most of the patients were boys and this reﬂects the
characteristics of our outpatient clinic. Despite not reaching
statistical signiﬁcance, girls had a higher occurrence of
positive DPT with the culprit drug when non-skin tested to
betalactams. Being female is usually considered a risk factor
for drug allergy in adults.26
Seventy-ﬁve percent of the non-skin tested children to
betalactams were aged six years or less. The decision not to
perform skin tests in these children was related to the idea
that such tests are generally considered difﬁcult to perform
in children younger than six years of age.7 Skin tested
children were older and this might partly explain the higher
prevalence of allergic diseases and positive skin tests to
airborne allergens.
Speciﬁc IgE for penicillin was positive only in a minority of
the cases. This is possibly due to methodological problems
and also depends upon the availability of the relevant
antigens.27 We should also note that most of the studied
reactions were non-immediate.
The role of atopy is still under debate. Atopic disease is
not generally considered a risk factor for the development
of ADRs.28 However, atopy seems to constitute a signiﬁcant
risk factor in ADR to NSAIDs29 and more recently seems to be
linked to a history of penicillin allergy.30 Asthma appears tobe a risk factor for severe reactions31 and in Singaporean
children with a reported ADR, they were more likely to have
a diagnosis of asthma compared to the control group.32 In
this study, a positive DPT was associated not only with
asthma but also with a diagnosis of food allergy. Factors such
as concurrent drug intake, infection, exercise and physical
activity and underlying food allergy may synergistically
interact with each other and precipitate a hypersensitivity
reaction or increase its severity.2
From our results, DPTs seem a safe procedure in the
paediatric population. Despite the lowest rate of DPTs in
skin tested children to betalactams, the number of positive
DPTs in the non-skin tested children was extremely low and
demonstrates that the majority of the suspected allergic
ADR are non-reproducible in a subsequent exposure. Our
ﬁnding supports the idea that most children with a
suspected drug allergy with betalactam are not truly
allergic. The decision to perform a DPT without previous
skin testing may be considered a relatively safe procedure in
children with a history of a low grade severity reaction,
namely that of an isolated cutaneous presentation. This
approach could be time saving and is less invasive. This is in
accordance with recent studies in paediatric age group.33
We should remember that skin tests to betalactams in
children face non-collaboration which is unusual in adults
and can thus raise interpretation difﬁculties.
Conclusions
Our results reinforce the need to perform appropriate
investigations in all children with a clinical history compa-
tible with betalactamic allergy. DPT seems a safe procedure
even in the absence of antecedent skin testing and this
could be a practical option in infants and pre-school
children, where skin testing could be painful and difﬁcult
to perform. Our data suggests that more caution should still
be exercised in children with asthma and a history of food
allergy.
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